arrow
P

Peter Ka-Fung Chiu

The Chinese University of Hong Kong
H指数:29
被引数:2,950

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of Intravesical Bacillus Calmette-Guérin Therapy Following Transurethral En Bloc Resection of Bladder Tumour: Post Hoc Analysis of a Randomised, Multicentre, Phase 3 Trial

经尿道整块膀胱肿瘤切除术后的膀胱内卡介苗疗法影响:一项随机、多中心、III期试验的事后分析

2025-11-010
OAAI
Impact of Human Development Index Category on Prostate Cancer Characteristics in Asia

人类发展指数类别对亚洲前列腺癌特征的影响

2025-10-010
PRE
Effect of Proton-Pump Inhibitor on Survival in Chinese Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer Receiving Upfront Combinatorial Docetaxel Treatment

质子泵抑制剂对接受 upfront combinatorial docetaxel 治疗的中国原发转移性激素敏感前列腺癌患者生存的影响

2025-09-260
OAAI
Transurethral Water Vapor Therapy (Rezūm) for Acute Urinary Retention with Obstructive Uropathy: A Prospective Cohort Study with One-Year Follow-Up

经尿道水蒸气疗法(Rezūm)治疗梗阻性尿路病所致急性尿潴留:一项为期一年的前瞻性队列研究

2025-08-090
OAAI
Prognostic value of PSMA PET/CT-Based local staging in predicting biochemical recurrence after radical prostatectomy

基于PSMA PET/CT的局部分期在预测根治性前列腺切除术后的生化复发中的预后价值

2025-07-280
OAAI
Assessment of the Reporting and Incidence of Prostate Cancer Unconventional Histologies in Tertiary Referral Institutions: An Under-reported but Exploding Phenomenon?

对三级转诊机构中前列腺癌非常规组织学类型的报告与发病率评估:一个未被充分报道但急剧增长的现象?

2025-06-010
OAAI
Treatment cycles per unit prostate volume (CPV) for transurethral water vapor therapy (Rezūm) in catheter-dependent patients

经尿道水蒸气疗法(Rezūm)在依赖导尿管患者中的每单位前列腺体积治疗周期(CPV)

2025-05-160
PRE